Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow limitation which is not fully reversible but it is preventable and treatable. Bronchodilators are used as first line agent for treatment of COPD. Aim: To assess the prescribing pattern of bronchodilators among the adult patients with Chronic obstructive pulmonary disease in pulmonology department. Method: A six month prospective observational study was conducted in pulmonology department of Tertiary care hospital in Bengaluru. Data demographics and medication was collected and prescribing pattern was compared with GOLD guidelines. Result: There are 73 patients were recruited for a study from department of pulmonology. As the study is based on prescription pattern of bronchodilators we assessed the prescription data of these 73 patients. Out of 73 patients there were 43 males (58.9%) and 30 females (41.1%) were affected by COPD and the most comorbidity was found to be diabetes mellitus and hypertension. The most prescribed bronchodilator was Levosalbutamol (53.1%) followed by Acebrophylline (30.8%). And the dose prescribed was 0.31, 0.63, 1.2 mg and 100mg. In this study bronchodilators prescribed was compared with Global Initiative for Obstructive Lung Disease guidelines. Conclusion: Levosalbutamal was prescribed frequently among bronchodilators to treat the inpatient or hospitalized patient with COPD. However all bronchodilators were prescribed according to the GOLD guidelines.